Srinagar, May 20 -- Srinagar- A proposal to rename Polycystic Ovary Syndrome has triggered fresh debate within the global medical community, with Indian researchers arguing that the suggested terminology fails to adequately reflect the condition's complexity, diversity and disease burden in countries like India and China.

The controversy emerged after a proposal to rename PCOS as "Polyendocrine Metabolic Ovarian Syndrome" (PMOS) was announced at the European Congress of Endocrinology and published in The Lancet. While supporters of the move say the new name better captures the metabolic and endocrine nature of the disorder, India's leading researchers have formally objected to the proposal, calling it scientifically incomplete and global...